Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 3.89 is 49% below its 5-year average of 7.56, near the low end of its 5-year range (1.71–26.22).
As of the fiscal period ended Tuesday, June 30, 2026. 21.48% below its 12-month average of 4.96.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 3.89.
CURRENT RATIO
3.89
CURRENT RATIO AVG TTM
4.96
CURRENT RATIO AVG 3Y
6.50
CURRENT RATIO AVG 5Y
7.56
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-21.48%
CURRENT VS 3Y AVG
-40.08%
CURRENT VS 5Y AVG
-48.50%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.34
median of 568 covered companies
CURRENT VS SECTOR MEDIAN
+16.42%
vs the sector median at left
Dogwood Therapeutics, Inc.
Market Cap
$54.48M
Current Ratio
3.89
TTM Avg
4.96
3Y Avg
6.50
5Y Avg
7.56
Market Cap
$51.06M
Current Ratio
3.74
TTM Avg
0.21
3Y Avg
0.34
5Y Avg
1.39
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Dogwood Therapeutics, Inc. (DWTX) | $54.48M | 3.89 | 4.96 | 6.50 | 7.56 |
| ImageneBio Inc (IMA)vs › | $53.01M | 21.47 | 12.14 | 11.08 | 9.81 |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $51.06M | 3.74 | 0.21 | 0.34 | 1.39 |
| Microbot Medical Inc. (MBOT)vs › | $52.41M | 18.56 | 12.85 | 8.01 | 9.80 |
| biote Corp. (BTMD)vs › | $50.28M | 1.43 | 1.27 | 3.36 | 3.09 |
| eXoZymes, Inc. (EXOZ)vs › | $55.97M | 3.81 | 5.31 | 3.36 | 3.21 |
| Apollomics, Inc. (APLM)vs › | $54.90M | 0.96 | 1.17 | 2.45 | 5.02 |
| INmune Bio, Inc. (INMB)vs › | $51.31M | 4.04 | 3.34 | 3.69 | 7.87 |
| Envoy Medical, Inc. (COCH)vs › | $50.95M | 1.73 | 0.89 | 0.86 | 0.91 |
| Connect Biopharma Holdings Limited (CNTB)vs › | $55.94M | 2.37 | 7.60 | 7.51 | 12.19 |
Current Ratio
3.89
Quick Ratio
3.89
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 3.89 |
| 2026-03-31 | 5.86 |
| 2025-12-31 | 2.76 |
| 2025-09-30 | 4.49 |
| 2025-06-30 | 7.80 |
| 2025-03-31 | 7.43 |
| 2024-12-31 | 5.21 |
| 2024-09-30 | 1.71 |
| 2024-06-30 | 7.27 |
| 2024-03-31 | 5.66 |
| 2023-12-31 | 11.62 |
| 2023-09-30 | 10.77 |
| 2023-06-30 | 10.02 |
| 2023-03-31 | 11.87 |
| 2022-12-31 | 8.02 |
| 2022-09-30 | 6.65 |
| 2022-06-30 | 4.76 |
| 2022-03-31 | 6.69 |
| 2021-12-31 | 12.37 |
| 2021-09-30 | 16.39 |
| 2021-06-30 | 26.22 |
| 2021-03-31 | 24.22 |
| 2020-12-31 | 20.55 |
| 2020-09-30 | 0.31 |
| 2020-06-30 | 0.66 |
| 2020-03-31 | 0.00 |
| 2019-12-31 | 0.19 |
| 2019-09-30 | 0.00 |
| 2019-06-30 | 0.00 |
